Stephen D. Nimer, M.D., named Mentor of the Year by the American Society of Hematology
Stephen D. Nimer, M.D., has been awarded the American Society of Hematology’s (ASH) Mentor Award for 2024. As director of Sylvester Comprehensive Cancer Center, Nimer is known for lifting up and guiding other researchers to create a collaborative environment that drives scientific discovery and quality patient care.
ReAlta Presenting New Results in aGVHD at American Society of Hematology 2024
By Karen Roman ReAlta Life Sciences said it is presenting new data at the American Society of Hematology (ASH) Annual Meeting in San Diego, California for its drug candidate in acute Graft-versus-Host Disease (aGVHD),
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing next-generation programmed T cell therapies, announces an oral presentation and three poster presentations at the American Society of Hematology (ASH) Annual Meeting,
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
Positive updates across all programs, including updates from ongoing clinical studies and new translational data in preclinical models supporting use in existing and additional indications Management hosted a conference call during the ASH meeting on Sunday,
NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
NeoGenomics will present research on hematologic malignancies and the prognostic effects of microenvironment signatures in primary CNS lymphoma at ASH
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting
Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated safety profile using a
BioPharma Dive2d
ASH24: Leukemia drug sequencing, sickle cell questions and a new kind of CAR-T
Data from Eli Lilly and AstraZeneca could help doctors decide treatment order in chronic lymphocytic leukemia. Elsewhere, ...
STAT4d
Pfizer’s abrupt withdrawal of sickle cell drug Oxbryta called ‘tone deaf’ at ASH conference
SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a ...
EurekAlert!4d
Dozens of presentations advance multiple myeloma research at the 2024 American Society for Hematology (ASH) meeting
Patients with multiple myeloma are living longer, thanks to a host of new immunotherapies and targeted drugs. But there is ...
Business Insider3d
New Combination Data of Secura Bio’s COPIKTRA® (duvelisib) Presented at the 2024 American Society of Hematology Meeting
presented new investigational combination data in an oral presentation at the 2024 American Society of Hematology (ASH) Meeting in San Diego, CA. Data from the investigator-sponsored study were ...
STAT4d
Study paints clearer picture of disadvantaged leukemia patients’ struggle to get bone marrow transplants
Study reveals how socioeconomic factors create barriers to bone marrow transplants for AML patients in disadvantaged ...
Fred Hutch7d
Fred Hutch PhD student honored by American Society of Hematology
Rasika Venkataraman, a third-year doctoral student working in the lab of Stanley C. Lee, PhD, at Fred Hutch Cancer Center, ...
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through more than sixteen ...
Business Wire10d
SonoThera Presents New Data at the American Society of Hematology (ASH) Annual Meeting Demonstrating the Potential of Targeted, Ultrasound-Mediated Gene Delivery to Liver
today announced it will present new data on its novel gene delivery platform and therapeutic programs at the 66 th American Society of Hematology (ASH) Annual Meeting and Exposition, being held ...
UC San Francisco6d
UCSF Health Experts Spotlight Advances at Hematology Conference
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 66th Annual Meeting and Exposition. This year’s ...
Yahoo Finance7h
Global Hematology Market to Exhibit Growth at a CAGR of ~8% by 2030 | DelveInsight
Hoffmann-La Roche Ltd, Horiba Ltd., Neomedica, Thermo Fisher Scientific, Agilent, and several others, are currently operating ...